P1.05-004 Surfactant Protein C is a Prognostic Marker in Resected Non-Small Cell Lung Cancer Ivan Macía, Juan Moya, Gemma Aiza, Ricard Ramos, Ignacio.

Slides:

Advertisements

Similar presentations

P2.03b-044 Treatment Outcome and the Role of Primary Tumor Therapy in a Cohort of Patients with Synchronous Oligometastatic NSCLC Jose Carlos Ruffinelli,

Advertisements

SC17.02 Lung Cancer in China: Challenges and Perspectives

Journal of Thoracic Oncology Volume 11, Issue 4, Pages (April 2016)

Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months Arturo Navarro-Martin, MD, Samantha Aso, MD, Jon Cacicedo,

Journal of Thoracic Oncology Volume 12, Issue 3, Pages (March 2017)

MA12.06 Tumor Spread through Air Spaces (STAS) in Lung Squamous Cell Cancer is an Independent Risk Factor: A Competing Risk Analysis Shaohua Lu, Takashi.

MA12.09 Comparative Histological Subtype Analysis of Lung Adenocarcinoma Tumor and Metastatic Lymph Nodes and the Prognostic Impact Shaohua Lu, Takashi.

Electronic Updates for JTO Readers

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

P Evolution of Survival in a Regional Population-Based US Lung Cancer Resection Cohort Raymond Osarogiagbon, Nicholas Faris, Matthew Smeltzer,

P The Effect of Two Interventions on Attainment of Surgical Quality Measures in Resected Non-Small Cell Lung Cancer (NSCLC) Nicholas Faris, Meredith.

OA20.03 Tumoral IL-7 Receptor is a Potential Target for Lung Adenocarcinoma Immunotherapy Ming-Ching Lee, Takashi Eguchi, Zachary Tano, Kyuichi Kadota,

P2.03b-023 Circulating Tumor DNA (ctDNA)-Based Genomic Profiling of Known Cancer Genes in Lung Squamous Cell Carcinoma (LUSC) Vincent Lam, Hai Tran,

The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer Peter Goldstraw, MB, FRCS, John J. Crowley, PhD

Frank Detterbeck, MD Journal of Thoracic Oncology

P The Impact of IASLC 8th Edition Updates for T-Classification for Lung Cancer in a US Population-Based Surgical Resection Cohort Matthew Smeltzer,

Volume 152, Issue 1, (January 2013)

P Pleural CEA and C-Reactive Protein in Patients with Lung Metastases and Malignant Pleural Effusion. A Prospective Case-Control Study Franco.

Journal of Thoracic Oncology Volume 12, Issue 5, Pages (May 2017)

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

Association between Congenital Lung Malformations and Lung Tumors in Children and Adults: A Systematic Review Arianna Casagrande, MD, Federica Pederiva,

Journal of Thoracic Oncology Volume 13, Issue 2, Pages (February 2018)

P SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer (NSCLC). A UK Randomized Phase III Trial Yenting Ngai,

P3.02b-125 Failure to Tyrosine Kinase Inhibitors and Patterns of Progression in Patients with Advanced Non-Small Cell Lung Cancer Feliciano Barron, Laura-Alejandra.

Journal of Thoracic Oncology Volume 11, Issue 2, Pages (February 2016)

P3.02b-062 Safety of Necitumumab and Abemaciclib Combination Therapy in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Benjamin Besse, Johan.

P1.22: Temporal Survival Improvement for Stage-II (T3N0M0) Lung Adenocarcinoma After Pulmonary Lobectomy Danny T. Nguyen, Jacques-Pierre Fontaine, Lary.

Journal of Thoracic Oncology Volume 12, Issue 7, Pages (July 2017)

A Different Method in Diagnosis of Multiple Primary Lung Cancer

PS02.17 A Biomarker-Driven Algorithm for Sequencing of Systemic Therapy for Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Survey of 25 Investigators

Journal of Thoracic Oncology Volume 12, Issue 8, Pages (August 2017)

P3.02b-061 A Phase II Study of Nab-Paclitaxel (Nab-P) in Patients with Advanced Non- Small Cell Lung Cancer (NSCLC) with EGFR Mutations Christina Baik,

Vamsidhar Velcheti, MD Journal of Thoracic Oncology

JCSE01.16 Positive Correlation Between Whole Genomic Copy Number Variant Scoring and the Grading System in Lung Non-Mucinous Invasive Adenocarcinoma

An Unmet Need in the WHO 2015 Biopsy Classification: Poorly Differentiated NSCCs with Positive Neuroendocrine Markers Jules L. Derks, MD Journal of.

P3-255: Tumor size as a prognostic factor for the survival of surgically treated stage Ia non-small cell carcinoma Gustavo A. Lyons, Silvia Quadrelli,

Journal of Thoracic Oncology Volume 12, Issue 10, Pages (October 2017)

P Circulating Biomarkers of Frailty Are Associated with a Poor Prognosis in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) Nicola.

P Comparison of Pulmonary Function after Robotic-Assisted Video- Thoracoscopic Lobectomies vs Segmentectomies Maria Echavarria, Anna Cheng, Frank.

Journal of Thoracic Oncology Volume 11, Issue 5, Pages (May 2016)

Journal of Thoracic Oncology Volume 11, Issue 8, Pages (August 2016)

MA Comparison of EORTC, PERCIST, PeterMac & Deauville PET Response Criteria after Radical ChemoRT in Non-Small-Cell Lung Cancer G. Turgeon, A.

Journal of Thoracic Oncology

It’s All in the “Swerve of the Curve”

P3.02a-023 Treatment Patterns and Early Outcomes of ALK+ Non-Small Cell Lung Cancer Patients Receiving Ceritinib: A Chart Review Study Edmond Bendaly,

MINI01.11: Radiotherapy Plus EGFR TKIs for Brain Metastasis in EGFR-Mutant Non– Small Cell Lung Cancer: A Retrospective Analysis of a Single Institution

Driven by Mutations: The Predictive Value of Mutation Subtype in EGFR-Mutated Non– Small Cell Lung Cancer Emily Castellanos, MD, Emily Feld, MD, Leora.

Jie Huang, Juan Peng, Linlang Guo, MD, PhD

Silvia Bielsa, MD, José Martín-Juan, MD, José M

MINI01.08: Disparities in the Management of Patients with Stage I Small Cell Lung Cancer (SCLC): A Surveillance, Epidemiology and End Results (SEER) Analysis

P Differentially Expressed microRNAs in Lung Adenocarcinoma Invert Effects of Copy Number Aberrations of Prognostic Genes Tomas Tokar, Emily.

Journal of Thoracic Oncology Volume 13, Issue 3, Pages (March 2018)

European Lung Cancer Conference (ELCC) 2016 Organisation

OA Video-Assisted Thoracoscopic Surgery vs

MA02.10 The First Year of Implementing a Lung Cancer Screening Program in an Urban Safety-Net Health System H. Hamann, S. Lee, T. Browning, C. Chavez,

P2.03b-002 Efficacy and Safety of WBRT Combined with Endostar in Patients with Advanced Non-Small Cell Lung Cancer Xiaorong Dong, Ruiguang Zhang, Xican.

Journal of Thoracic Oncology Volume 13, Issue 6, Pages (June 2018)

Journal of Thoracic Oncology

IASLC 6th Latin American Conference on Lung Cancer

PS01.37: Comparison Between Sanger Sequencing and ARMS qPCR Method for EGFR Gene Mutation Detection of Non–Small Cell Lung Cancer Jiexia Zhang, Xiaoshun.

P Post-Recurrence Survival Analysis of Stage I Non-Small Cell Lung Cancer: Prognostic Significance of Local Treatment Kanghoon Lee, Hyeong Ryul.

P1. 02: Lung Cancer - A Previously Years Survival Study

PUB019 Preoperative Needle Biopsy and Tumor Spread through Alveolar Spaces (STAS) in Resected Lung Adenocarcinomas Koji Kameda, Takashi Eguchi, Shaohua.

A Review of First-Line Treatment for Small-cell Lung Cancer

MA01.03 The Non-Invasive LuCED® Test for Detection of Early Stage Lung Cancer Michael Meyer, Timothy Bell, Daniel Sussman, David Wilbur, Chris Presley,

Y. Lou, R. Manochakian, J. Cochuyt, D. Hodge, S. Ailawadhi

Volume 148, Issue 1, (January 2012)

Robert Comis, MD, The Passing of a “Lung Man”

ED04.01 Surgery in Bronchopulmonary Typical and Atypical Carcinoids

Reply to “Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer: Methodological Issues” Boris Sepesi,

Presentation transcript:

P1.05-004 Surfactant Protein C is a Prognostic Marker in Resected Non-Small Cell Lung Cancer Ivan Macía, Juan Moya, Gemma Aiza, Ricard Ramos, Ignacio Escobar, Francisco Rivas, Anna Ureña, Gabriela Rosado, Pau Rodríguez- Taboada, Samantha Aso, Susana Padrones, Carlos Déniz, Ernest Nadal, Gabriel Capella Journal of Thoracic Oncology Volume 12, Issue 1, (January 2017) DOI: 10.1016/j.jtho.2016.11.788 Copyright © 2016 Terms and Conditions

Journal of Thoracic Oncology 2017 12, DOI: (10. 1016/j. jtho. 2016. 11 Copyright © 2016 Terms and Conditions